Serial Assessment of Biomarkers and Risk of Stroke or Systemic Embolism and Bleeding in Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serial Assessment of Biomarkers and the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
Eur Heart J 2021 Mar 24;[EPub Ahead of Print], K Oyama, RP Giugliano, DD Berg, CT Ruff, P Jarolim, M Tang, SA Murphy, HJ Lanz, MA Grosso, EM Antman, E Braunwald, DA MorrowFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.